[go: up one dir, main page]

MX2015013801A - Radiolabelling process. - Google Patents

Radiolabelling process.

Info

Publication number
MX2015013801A
MX2015013801A MX2015013801A MX2015013801A MX2015013801A MX 2015013801 A MX2015013801 A MX 2015013801A MX 2015013801 A MX2015013801 A MX 2015013801A MX 2015013801 A MX2015013801 A MX 2015013801A MX 2015013801 A MX2015013801 A MX 2015013801A
Authority
MX
Mexico
Prior art keywords
composition
facbc
radiolabelling process
radiolabelling
amino
Prior art date
Application number
MX2015013801A
Other languages
Spanish (es)
Other versions
MX368061B (en
Inventor
Torild Wickstrom
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of MX2015013801A publication Critical patent/MX2015013801A/en
Publication of MX368061B publication Critical patent/MX368061B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/15—Saturated compounds containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to a novel composition comprising 1-amino-3-[18F]-fluorocyclobutanecarboxylic acid ([18F]-FACBC) wherein said composition has certain superior properties in comparison with known compositions comprising [18F]-FACBC. Also provided by the invention is a method to obtain said composition.
MX2015013801A 2013-03-28 2014-03-28 Radiolabelling process. MX368061B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1305687.4A GB201305687D0 (en) 2013-03-28 2013-03-28 Radiolabelling process
PCT/EP2014/056344 WO2014154886A1 (en) 2013-03-28 2014-03-28 Radiolabelling process

Publications (2)

Publication Number Publication Date
MX2015013801A true MX2015013801A (en) 2016-02-16
MX368061B MX368061B (en) 2019-09-18

Family

ID=48444922

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015013801A MX368061B (en) 2013-03-28 2014-03-28 Radiolabelling process.

Country Status (12)

Country Link
US (2) US9999692B2 (en)
EP (1) EP2978456B1 (en)
JP (1) JP6500011B2 (en)
KR (1) KR102218249B1 (en)
CN (1) CN105120905B (en)
AU (1) AU2014242897B2 (en)
CA (1) CA2908029C (en)
ES (1) ES2864702T3 (en)
GB (1) GB201305687D0 (en)
MX (1) MX368061B (en)
RU (1) RU2675371C2 (en)
WO (1) WO2014154886A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201305687D0 (en) 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
US20220001034A1 (en) * 2014-06-30 2022-01-06 Ge Healthcare Limited Novel formulation and method of synthesis
GB201621864D0 (en) * 2016-12-21 2017-02-01 Ge Healthcare Ltd Solid phase conditioning

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808146A (en) 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
EP1889834B1 (en) * 2005-05-23 2011-04-20 Nihon Medi-Physics Co., Ltd. Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same
JP5349960B2 (en) * 2005-06-23 2013-11-20 エモリー ユニバーシティー Stereoselective synthesis of amino acid analogs for tumor imaging
CA2612186A1 (en) 2005-06-23 2007-01-04 Emory University Imaging agents
NZ572936A (en) * 2006-05-11 2011-01-28 Nihon Mediphysics Co Ltd Process for production of [18F]1-amino-3-fluorocyclobutanecarboxylic acid, [18F]FACBC
US8790620B2 (en) * 2006-12-21 2014-07-29 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic imaging agent
US8343459B2 (en) 2007-02-13 2013-01-01 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
JP5732198B2 (en) * 2007-12-19 2015-06-10 日本メジフィジックス株式会社 Method for producing radioactive fluorine-labeled organic compound
CA2785179C (en) 2009-10-08 2018-06-05 Ge Healthcare Limited Purification method
JP6018581B2 (en) * 2010-12-29 2016-11-02 ジーイー・ヘルスケア・リミテッド Elution solution
PL2793954T3 (en) * 2011-12-21 2021-04-06 Ge Healthcare Limited 18f-fluciclovine compositions in citrate buffers
GB201305687D0 (en) 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process

Also Published As

Publication number Publication date
CN105120905A (en) 2015-12-02
KR102218249B1 (en) 2021-02-22
KR20150136598A (en) 2015-12-07
US20180177900A1 (en) 2018-06-28
ES2864702T3 (en) 2021-10-14
RU2015138540A (en) 2017-05-03
BR112015024344A2 (en) 2017-07-18
WO2014154886A1 (en) 2014-10-02
US9999692B2 (en) 2018-06-19
EP2978456A1 (en) 2016-02-03
AU2014242897A1 (en) 2015-08-27
MX368061B (en) 2019-09-18
JP2016515564A (en) 2016-05-30
CN105120905B (en) 2021-07-06
GB201305687D0 (en) 2013-05-15
AU2014242897B2 (en) 2018-11-08
JP6500011B2 (en) 2019-04-10
RU2015138540A3 (en) 2018-03-01
CA2908029A1 (en) 2014-10-02
RU2675371C2 (en) 2018-12-19
US20160051710A1 (en) 2016-02-25
CA2908029C (en) 2021-05-04
EP2978456B1 (en) 2021-03-17

Similar Documents

Publication Publication Date Title
IN2015KN00262A (en)
WO2014086982A3 (en) Stable metal compounds, their compositions and methods of their use
IN2014DN09891A (en)
NZ607149A (en) Galacto-oligosaccharide-containing composition and a method of producing it
IN2015KN00323A (en)
MY180098A (en) Novel process for preparing silicas
GB2487563B (en) A pellet
EA201491195A1 (en) METHOD FOR OBTAINING A COMPOSITION CONTAINING GALACT-OLIGOSACCHARIDES
MY194466A (en) Heterophasic polypropylene composition
MX2014002996A (en) Bispecific anti-egfr/anti igf-1r antibodies.
MX2015007518A (en) Methods for treating pruritus.
MX345926B (en) Novel compositions, preparation thereof and use thereof for production of cast polyamides.
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
IN2014DN07691A (en)
IN2014DN10078A (en)
MX2016004664A (en) Late stage addition of rheology modifier.
EP4289819A3 (en) Process for the preparation of enantiomerically enriched 3-aminopiperidine
MX368061B (en) Radiolabelling process.
IN2015DN00085A (en)
IN2014DN03245A (en)
IN2014MN01829A (en)
WO2013128173A3 (en) Skincare compositions
MX2014003936A (en) Method for producing dithiine tetracarboximides.
PT2928927T (en) Process to produce polyvinyl-ester compositions with low residual monomer content
PH12014501760B1 (en) Method for stereoselective synthesis of 1,4-protected 9-hydroxy-5-oxo-1,4-diaza-spiro[5.5]undecanes

Legal Events

Date Code Title Description
FG Grant or registration